AstraZeneca
AstraZeneca’s Priority Review good news provides reprieve
August 2, 2017Sales and Marketing AstraZeneca, FDA, biotech, drugs, pharma, pharmaceutical
If there was a company that needed a series of good news stories this week, it was AstraZeneca. The blow …
AstraZeneca scores second accelerated FDA review in 2 days for blood cancer drug
August 1, 2017Manufacturing and Production, Sales and Marketing AstraZeneca, FDA, acalabrutinib, biotech, drugs, life sciences, pharma, pharmaceutical
It’s been a rollercoaster week for AstraZeneca.
AZ’s Imfinzi scores FDA breakthrough therapy designation in wake of major trial failure
July 31, 2017Sales and Marketing AstraZeneca, Imfinzi, drugs, healthcare, mystic, phaarmaceutical, pharma
Still reeling from the public reaction to the flop of its key Mystic trial, where its injectable immunotherapy drug Imfinzi …
AZ attempts to clear dust of Mystic trial with $8.5 billion MSD deal
July 27, 2017Medical Communications, Sales and Marketing AstraZeneca, MSD, Merck, biotech, drugs, immunotherapy, mystic, pharma, pharmaceutical
It will be some time before the Mystic catastrophe hoo-ha dies down for AstraZeneca but it made a pre-emptive move …
AZ’s ‘blockbuster’ lung cancer drug fails, Q2 revenue falls
July 27, 2017Research and Development, Sales and Marketing AstraZeneca, biotech, drugs, healthcare, pharma, pharmaceutical
The long-awaited results for AstraZeneca’s Mystic trial have been revealed and, in a shocking setback for the company, it was …
Top Ten most popular articles on Pharmafile.com this week
July 21, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Teva, biotech, brexit, drugs, healthcare, pharma, pharmaceutical, psoriasis, top ten
The week was characterised by two big psoriasis approval stories, while Amgen’s osteoporosis treatment was knocked back. Novartis CEO Joe …
AstraZeneca’s Soriot Teva switch scotched
July 17, 2017Medical Communications, Sales and Marketing AstraZeneca, Soriot, Teva, biotech, drugs, pharma, pharmaceutical
The rumours, beginning with a report by Israeli newspaper Calcalist, had suggested that Pascal Soriot, CEO of AstraZeneca, appeared to …
AstraZeneca’s CEO set for shock switch to Teva
July 13, 2017Medical Communications AstraZeneca, Teva, biotech, drugs, pascal soriot, pharma, pharmaceutical
It is no secret that Teva has been on the lookout for a new CEO and they had already been …
AstraZeneca appoint new MD for India
July 7, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, India
AstraZeneca announced a new Managing Director for AstraZeneca Pharma India, with Gagan Singh Bedi beginning the role on 3 July. …
AstraZeneca generates $600 million from just two drug sales
July 3, 2017Manufacturing and Production, Sales and Marketing AstraZeneca, Seloken, Zomig
AstraZeneca is expected to generate almost $600 million from just two drug sales: Zoming, a migraine therapy, and Seloken, a …
GSK signs $43 million AI-based drug discovery deal with Exscientia
July 3, 2017Research and Development, Sales and Marketing AstraZeneca, Exscientia, GSK
With AI partnerships becoming increasingly common in the life sciences industry, it has emerged that GSK is to partner up …
New Pfizer EU approval offers first treatment option for leukaemia subtype
July 3, 2017Sales and Marketing AstraZeneca, Besponsa, EU, European Commission
Pfizer has revealed that its drug Besponsa (inotuzumab ozogamicin) has received approval from the European Commission as a monotherapy for …
NICE recommends AstraZeneca lung treatment
July 3, 2017Sales and Marketing AstraZeneca, Daxas, NICE
AstraZeneca’s Daxas (roflumilast) has received recommendation from NICE for the treatment of chronic obstructive pulmonary disease (COPD) it has emerged, …
GSK’s new President of Global Pharma join date revealed as AZ drops lawsuit
June 20, 2017Business Services, Manufacturing and Production AZ, AstraZeneca, GSK, GlaxoSmithKline, Luke Miels
The transition of former AstraZeneca Executive Vice President for Europe Luke Miels to rival pharma giant GlaxoSmithKline has not been …
AZ withdraws Brilinta batch for containing the wrong drug after packaging mix-up
June 6, 2017Manufacturing and Production AstraZeneca
The United Arab Emirates Ministry of Health and Prevention has called for the withdrawal of a batch of AstraZeneca’s cardiovascular …
